Format

Send to

Choose Destination
Exp Physiol. 2013 Jan;98(1):19-24. doi: 10.1113/expphysiol.2011.063321. Epub 2012 Jul 30.

Nuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy.

Author information

1
Boston University, Department of Health Sciences, 635 Commonwealth Avenue, Boston, MA 02215, USA.

Abstract

The nuclear factor-κB (NF-κB) signalling pathway is a necessary component of adult skeletal muscle atrophy resulting from systemic illnesses or disuse. Studies showing a role for the NF-κB pathway in muscle disuse include unloading, denervation and immobilization, and studies showing a role for NF-κB in systemic illnesses include cancer, chronic heart failure and acute septic lung injury. Muscle atrophy due to most of these triggers is associated with activation of NF-κB transcriptional activity. With the exception of muscle unloading, however, there is a paucity of data on the NF-κB transcription factors that regulate muscle atrophy, and little is known about which genes are targeted by NF-κB transcription factors during atrophy. Interestingly, in some cases it appears that the amelioration of muscle atrophy by genetic inhibition of NF-κB signalling proteins is due to effects that are independent of the downstream NF-κB transcription factors. These questions are prime areas for investigation if we are to understand a key component of muscle wasting in adult skeletal muscle.

PMID:
22848079
PMCID:
PMC3505235
DOI:
10.1113/expphysiol.2011.063321
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center